# Galectin-3 Blockade in Patients With High Blood Pressure

> **NCT01960946** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 59 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DIETARY_SUPPLEMENT:** Modified Citrus Pectin (MCP) vs placebo

## Key facts

- **NCT ID:** NCT01960946
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2018-08-30
- **Final completion:** 2018-08-30
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2021-02-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01960946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01960946, "Galectin-3 Blockade in Patients With High Blood Pressure". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01960946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*